SCHEMBL5166005

SCHEMBL5166005

CCn1c(=O)c(N2CCCCC2)nc2ccccc21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 4/20 0.58
KDM4E B2RXH2 4/20 0.58
ALDH1A1 P00352 2/20 0.58
HSD17B10 Q99714 2/20 0.58
LMNA P02545 2/20 0.58
HPGD P15428 1/20 0.58
CASP1 P29466 2/20 0.55
CASP7 P55210 2/20 0.55
MAPT P10636 1/20 0.51
TSHR P16473 1/20 0.51
GFER P55789 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
ATM Q13315 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
KMT2A Q03164 1/20 0.50
CTDSP1 Q9GZU7 1/20 0.50
CYP1A2 P05177 2/20 0.49
CYP2D6 P10635 1/20 0.49
HTT P42858 1/20 0.49
PIK3CA P42336 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28034968 0.86 CFTR (0.59) ALDH1A1LMNAKMT2ACYP1A2CYP2D6
SCHEMBL16649554 0.81 KMT2A (0.68) ALDH1A1LMNAMAPTKMT2ANPSR1
SCHEMBL2641012 0.76 CFTR (0.56)
SCHEMBL979684 0.75 KDM4E (0.69) MAPK1KDM4EALDH1A1HSD17B10LMNA
SCHEMBL8891951 0.75 MAPT (0.44) MAPK1KDM4EALDH1A1HSD17B10LMNA
SCHEMBL5166280 0.74 TP53 (0.45) MAPK1KDM4EALDH1A1HSD17B10LMNA
SCHEMBL981293 0.74 KDM4E (0.67) MAPK1KDM4EALDH1A1HSD17B10LMNA
SCHEMBL981898 0.74 KDM4E (1.00) MAPK1KDM4EALDH1A1HSD17B10LMNA
SCHEMBL5545639 0.74 KDM4E (0.67) MAPK1KDM4EALDH1A1HSD17B10LMNA
SCHEMBL31315695 0.73 ALDH1A1 (0.51) MAPK1KDM4EALDH1A1HSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893599-A1 COMPOUNDS FOR THE TREATMENT OF MULTI-DRUG RESISTANT BACTERIAL INFECTIONS AstraZeneca AB (SE) 2008-03-05 EP disclosed
WO-2006134378-A1 COMPOUNDS FOR THE TREATMENT OF MULTI-DRUG RESISTANT BACTERIAL INFECTIONS ASTRAZENECA AB (SE) 2006-12-21 WO disclosed